MC-1 (pyridoxal 5′-phosphate): novel therapeutic applications to reduce ischaemic injury

Bibliography

• BRAUNWALD E, KLONER RA: reperfusion: a double-edged sword?' Clin. Invest. (1985) 76:1713–1719.
   Google Scholar
• KLONER RA: Does reperfusion injury exist in humans?I Am. Coll. Cardiol. (1993) 21:537–545.
   PubMed Web of Science ®Google Scholar
• ROE MT, OHMAN EM, MAAS AC et al: Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. Am. Coll. Cardiol (2001) 37:9–18.
   PubMed Web of Science ®Google Scholar
• AMERICAN HEART ASSOCIATION: Heart disease and stroke statistics - 2005 update. Dallas, USA (2005).
   Google Scholar
• LOPEZ AD, MURRAY CC: The global burden of disease, 1990-2020. Nat. Med. (1998) 4:1241–1243.
   PubMed Web of Science ®Google Scholar
• WANG X, DAKSHINAMURTI K, MUSAT S, DHALLA NS: Pyridoxal-5'-phosphate is an ATP receptor antagonist in freshly isolated cardiomyocytes. Mol. (1999) 31:1063–1072.
   Google Scholar
• KANDZARI DE, LABINAZ M, CANTOR WJ et al.: Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to eliminate necrosis and damage trial). Am. J. Cardiol (2003) 92:660–664.
   PubMed Web of Science ®Google Scholar
• •Clinical trial evaluating the cardioprotective effects of MC-1 in high-risk PCI patients.
   Google Scholar
• FONDA ML, TRAUSS C, UM: The binding of pyridoxal 5'-phosphate to human serum albumin. Arch. Biochem. Biophys. (1991) 288:79–86.
   PubMed Web of Science ®Google Scholar
• BODE W, VAN DEN BERG H: Pyridoxal-5'-phosphate and pyridoxal biokinetics in wistar rats fed graded levels of vitamin-6. J. Nut]: (1991) 121:1738–1745.
   Google Scholar
• MIDDLETON HM: Intestinal absorption of pyridoxal-5'-phosphate: disappearance from perfused segments of rat jejunum in vivo. J. Num. (1979) 109:975–981.
   Google Scholar
• MIDDLETON HM: Intestinal hydrolysis of pyridoxal 5'-phosphate in vitro and in vivo in the rat. Effect of protein binding and pH. Gastroenterology (1986) 91:342–350.
   Google Scholar
• MEHANSHO H, HAMM MW, HENDERSON LM: Transport and metabolism of pyridoxal and pyridoxal phosphate in the small intestine of the rat. J. Num. (1979) 109:1542–1551.
   Google Scholar
• TURNER JM: Pyridoxal phosphate breakdown by an alkaline phosphatase preparation. Biochem. J. (1961) 80:663–668.
   PubMed Web of Science ®Google Scholar
• MORISUE T, MORINO Y, SAKAMOTO Y, ICHIHARA K: Enzymatic studies on pyridoxine metabolism III. Pyridoxine phosphate oxidase. Biochem. (1960) 48:28–36.
   Google Scholar
• ELIOT AC, KIRSCH JF: Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations. Ann. Rev Biochem. (2004) 73:383–415.
   PubMed Web of Science ®Google Scholar
• VENEGAS A, MARTIAL J, VALENZUELA P: Active site-directed inhibition of E. coil DNA-dependent RNA polymerase by pyridoxal 5'-phosphate. Biochem. Biophys. Res. Commun. (1973) 55:1053–1059.
   Google Scholar
• MARTIAL J, ZALDIVAR J, BULL P, VENEGAS A, VALENZULA P: Inactivation of rat liver RNA polymerases I and II and yeast RNA polymerase I by pyridoxal 5'-phosphate: evidence for the participation of lysyl residues at the active site. Biochemistry (1975) 14:4907–4911.
   PubMed Web of Science ®Google Scholar
• BASU A, TIRUMALAI RS, MODAK MJ: Substrate binding in human immunodeficiency virus reverse transcriptase. An analysis of pyridoxal 5'-phosphate sensitivity and identification of lysine 263 in the substrate-binding domain. Biol. Chem. (1989) 264:8746–8752.
   Google Scholar
• MODAK MJ: Observations on the pyridoxal 5'-phosphate inhibition of DNA polymerases. Biochemistry (1976) 15:3620–3626.
   PubMed Web of Science ®Google Scholar
• DIFFLEY JF: Affinity labeling the DNA polymerase a complex: pyridoxal 5'-phosphate inhibition of DNA polymerase and DNA primase activities of the DNA polymerase-a complex from Drosophila melanogaster embryos.. Biol. Chem. (1988) 263:14669–14677.
   Web of Science ®Google Scholar
• KATUNUMA N, MATSUI A, INUBUSHI T et al.: Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathespin K in vitro and in vivo. Biochem. Biophys. Res. Commun. (2000) 267:850–854.
   PubMed Web of Science ®Google Scholar
• YAMASHIMA T, ZHAO L, WANG XD, TSUKADA T, TONCHEV AB: Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys. Num. Neurosci. (2001) 4:389–397.
   PubMed Web of Science ®Google Scholar
• MILAVETZ JJ, GIEBEL DW, CHRISTIAN TF, SCHWARTZ RS, HOLMES DR, GIBBONS RJ: Time to therapy and salvage in myocardial infarction. Am. Coll. Cardiol. (1998) 31:1246–1251.
   PubMed Web of Science ®Google Scholar
• DE LUCA G, SURYAPRANATA H, ZIJLSTRA F et al.: ZWOLLE MYOCARDIAL INFARCTION STUDY GROUP. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary. J. Am. Coll Cardiol (2003) 42:991–997.
   Google Scholar
• LANGLOIS PF, GAWRYL MS: Detection of the terminal complement complex in patient plasma following acute myocardial infarction. Atherosclerosis (1988) 70:95–105.
   PubMed Web of Science ®Google Scholar
• SHERIDAN FM, COLE PG, D: Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model. Circulation (1996) 93:1784–1787.
   PubMed Web of Science ®Google Scholar
• REIMER KA, LOWE JE, MM, JENNINGS RB: The wavefront phenomenon of ischemic cell death: myocardial infarct size versus duration of coronary occlusion in dogs. Circulation (1977) 56:786–794.
   PubMed Web of Science ®Google Scholar
• BOLLI R: Mechanism of myocardial 'stunning'. Circulation (1990) 82:723–738.
   PubMed Web of Science ®Google Scholar
• CLEMENS MG, FORRESTER T: Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia.. (1981) 312:143–158.
   Google Scholar
• FORRESTER T, WILLIAMS CA: Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia. Physiol. (1977) 268:371–390.
   Web of Science ®Google Scholar
• INGERMAN CM, SMITH JB, SILVER MJ: Direct measurement of platelet secretion in whole blood. Thromb. Res. (1979) 16:335–344.
   PubMed Web of Science ®Google Scholar
• SHINOZUKA K, HASHIMOTO M, MASUMURA S, BJUR RA, DP, HATTORI K: In vitro studies of release of adenosine nucleotides and adenosine from rat vascular endothelium in response to al-adrenoceptor stimulation. BE J. Pharmacol (1994) 113:1203–1208.
   PubMed Web of Science ®Google Scholar
• YANG S, CHEEK DJ, WESTFALL DP, BUXTON IL: Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ. Res. (1994) 74:401–407.
   Google Scholar
• VASSORT G: Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev (2001) 81:767–807.
   PubMed Web of Science ®Google Scholar
• TREZISE DJ, BELL NJ, KHAKH BS, MICHEL AD, HUMPHREY PA:2 purinoreceptor antagonist properties of pyridoxa1-5-phosphate. Eur. I Pharmacol (1994) 259:295–300.
   PubMed Web of Science ®Google Scholar
• DUBYAK GR, EL MOATASSIM C: Signal transduction via P2-purinergic receptors for ATP and other nucleotides. Am. J. Physiol (1993) 265:C577–C606.
   PubMed Web of Science ®Google Scholar
• HARDEN TK, BOYER JL, RA: P2-purinergic receptors: subtype associated signaling response and structure. Ann. Rev Pharmacol Toxicol. (1994) 35:541–579.
   Web of Science ®Google Scholar
• HOURANI SM, HALL DA: P2T purinoceptors: ADP receptors on platelets. Ciba Found. Symp. (1996) 198:53–64.
   PubMedGoogle Scholar
• DUBYAK GR, COWEN DS, HM: Activation of inositol phospholipid signaling system by receptors for extracellular ATP in human neutrophils, monocytes, and neutrophilimonocyte progenitor cells. Ann. NV Acad. Sci. (1988) 551:218–237.
   PubMed Web of Science ®Google Scholar
• AKBAR GK, MILLS DC, KUNAPULI SP: Characterization of extracellular nucleotide-induced Mac-1 (a/v(32 integrin) surface expression on peripheral blood leucocytes. Biochem. Biophys. Res. Commun. (1997) 233:71–75.
   PubMed Web of Science ®Google Scholar
• VENTURA MA, THOMOPOULOS P: ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3. Mol. Pharmacol (1995) 47:104–114.
   PubMed Web of Science ®Google Scholar
• VULCHANOVA L, ARVIDSSON U, RIEDL M et al.: Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc. Nati Acad. Sci. USA (1996) 93:8063–8067.
   PubMed Web of Science ®Google Scholar
• BURNSTOCK G: Vascular control by purines with emphasis on the coronary system. Eur. Heart J. (1989) 10(Suppl. F):15–21.
   Google Scholar
• WANG CX, YANG T, NOOR R, SHUAIB A: Role of MC-1 alone and in combination with tissue plasminogen activator in focal ischemic brain injury in rats. J. Neurosurg. (2005) 103:165–169.
   PubMed Web of Science ®Google Scholar
• KONG TQ, DAVIDSON CJ, SN, TAUKE JT, PARKER MA, BONOW RO: Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA (1997) 277:461–466.
   PubMed Web of Science ®Google Scholar
• TARDIFF BE, CALIFF RM, TCHENG JEet al: Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J. Am. Coll. Cardiol (1999) 33:88–96.
   PubMed Web of Science ®Google Scholar
• HARRINGTON RA, LINCOFF AM, CALIFF RM et al: Characteristics and of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). I Am. Coll. Cardiol. (1995) 25:1693–1699.
   PubMed Web of Science ®Google Scholar
• SAUCEDO JF, MEHRAN R, DANGAS G et al.: Long-term clinical events following creatine-myocardial band isoenzyme elevation after successful coronary stenting. J. Am. Coll. Cardiol (2000) 35:1134–1141.
   PubMed Web of Science ®Google Scholar
• GRANDE P, CHRISTIANSEN C, PEDERSEN A: Influence of acute myocardial infarct size on acute and one-year mortality. Eur. Heart J. (1983) 4:20–25.
   PubMedGoogle Scholar
• LAMAS GA, FLAKER GC, MITCHELL G et al. FOR THE SURVIVAL AND VENTRICULAR ENLARGEMENT INVESTIGATORS: Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation (1995) 92:1101–1109.
   PubMed Web of Science ®Google Scholar
• MAYNARD C, WEAVER WD, LIT WIN PE et al. FOR THE MITI PROJECT INVESTIGATORS: Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (The Myocardial Infarction Triage and Intervention Project). Am. J. Cardiol (1993) 72:877–882.
   Google Scholar
• DI VIRGILIO F, CHIOZZI P, FALZONI S et al: Cytolytic P2X purinoceptors. Cell Death Differ. (1998) 5:191–199.
   PubMed Web of Science ®Google Scholar
• FRISO S, JACQUES PF, WILSON PW et al.: Low circulating vitamin B6 is associated with elevation of the inflammatory marker C-reactive protein independently of homocysteine levels. Circulation (2001) 103:2788–2791.
   PubMed Web of Science ®Google Scholar